Prosecution Insights
Last updated: October 02, 2026
Application No. 18/671,450

INTEGRATED PRESSURE SENSING AND REDISTRIBUTION FOR OPERATING TABLE PADS

Final Rejection §103§112
Filed
May 22, 2024
Priority
May 22, 2023 — provisional 63/468,068 +1 more
Examiner
NEWTON, JASON TODD
Art Unit
3673
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Baxter Medical Systems GmbH + Co. Kg
OA Round
2 (Final)
83%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
721 granted / 872 resolved
+30.7% vs TC avg
Strong +22% interview lift
Without
With
+22.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 3m
Avg Prosecution
28 currently pending
Career history
898
Total Applications
across all art units

Statute-Specific Performance

§101
3.8%
-36.2% vs TC avg
§103
35.0%
-5.0% vs TC avg
§102
18.5%
-21.5% vs TC avg
§112
36.9%
-3.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 872 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Remarks This communication is in response to the reply received on 05-21-2026. Per the reply, page 7, claims 12, 15, and 19 are cancelled, claims 1, 8-10, 13, 14, 16-18 and 20 are amended and claims 21-22 are added. Claims 1-11, 13-14, 16-18 and 20-22 are currently pending and have been examined. The 35 U.S.C. 112 rejection of claims 9, 13-14, 16-17 and 20 is withdrawn as addressed via amendment. Claims 1-11, 13-14, 16-18 and 20-22 are rejected as provided below. Information Disclosure Statement The information disclosure statement (IDS) submitted on 09-26-2024 is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Election/Restrictions Applicant’s election without traverse of species I (fig. 1A), III (fig. 3A) and V (fig. 4a) and invention I (corresponding to claims 1-11, 13, 14, 16-18, and 20) in the reply filed on 10-13-2025 is acknowledged. Drawings The drawings filed 05-22-2024 are acceptable. Claim Interpretation Under 35 USC § 112 No claim elements in this application are presumed to invoke 35 U.S.C. 112(f). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-7 and 13-14 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented). As to claim 1. D1 discloses a patient table (fig. 1) comprising: a patient support surface (generally top surface of mattress 22) for supporting a patient (this is interpreted as a statement of intended use and it has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2d 1647 (1987)); and at least one pressure redistribution assembly (fig. 1 and fig. 4), each of the at least one pressure redistribution assemblies comprising: a pressure sensing assembly (sensing mat 20 in fig. 4 including associated electrical conductors 50 and preprocessing circuit boards 52. Each preprocessing circuit board may, in turn, be connected to an electronic control module 54) located proximate to the patient support surface (fig. 1) to measure a pressure between the patient support surface and the patient at a plurality of sensing regions ([0034] Circuit boards 52 and control module 54 are designed to perform all of the electrical work necessary to determine the pressures being exerted at each of the pressure sensor locations of mat 20); a repositioning assembly (controller 26 and fluid bladders or cells 28) located between the patient support surface and the pressure sensing assembly, the repositioning assembly including a plurality of inflatable cells (fluid bladders or cells 28) overlapping the plurality of sensing regions ([0014] and fig 1 where sensing mat 20 above inflatable cell 28 = sensing region), a medium located within the inflatable cells ([0016] fluid inside cells), and an actuator for selectively redistributing a quantity of the medium between the inflatable cells ([0037] single controller, such as control module 54, may be used to control bladder or cell inflation and deflation); and a processor (mattress controller 26 and/or electronic control module includes memory [0017]) and a memory ([0017]) containing instructions that, when executed by the processor (mattress controller 26 includes memory [0017]), cause the processor (mattress controller 26 includes memory [0017]) to: receive a measurement of the pressure from the pressure sensing assembly ([0017] mattress controller 26 will include a set of electronic components that are designed to carry out the functions of controlling the inflation and deflation of the bladders or cells 28, and communicating with pressure mat 20; electronic control module 54 is in electrical communication with mattress controller 26); determine if the measurement of pressure is above a threshold ([0038] When control module 54 outputs information indicating that a specific sensor is detecting a pressure that is undesirably high, mattress controller 26 will be able to determine which air zone this corresponds to and adjust the pressure in that zone accordingly; [0040]); and if the measurement of pressure is above the threshold ([0038] and [0040]), generate a signal to redistribute the medium ([0038]). D1 does not disclose the repositioning assembly is located between the patient support surface and the pressure sensing assembly as amended. However, D4 (previously presented), is in a related field of patient support surface control and teaches it is known (see e.g. figs. 27-30) to provide a repositioning assembly (plurality of air bladders 712 in fig. 27) located between a patient support surface(upper ticking 714) and a pressure sensing assembly (touch sensor 716). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D4 (directed to a patient support surface control) and arrived at pressure sensing mattress with a repositioning assembly located between the patient support surface and the pressure sensing assembly as the amended claim requires. One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. choosing from a limited number of arrangements to arrange the sensor and the repositioning assembly under the patient) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. both the repositioning assembly and the sensor need to be under a patient). Further, the claimed arrangement is obvious as a matter of design choice. At the time of the invention, it would have been obvious to a person of ordinary skill in the art to arrange the repositioning assembly between the patient support surface and the pressure sensing assembly. Applicant has not disclosed that such an arrangement is used for a particular purpose or solves a stated problem. One of ordinary skill in the art, furthermore, would have expected Applicant’s invention to perform equally well with the claimed arrangement or as the arrangement disclosed in D1 because both provide a measure of pressure at a desired point, and both the repositioning assembly and the sensor need to be under a patient, therefore the number of functional arrangements is limited. Therefore, it would have been obvious to combine to one of ordinary skill in this art to arrange the repositioning assembly between the patient support surface and the pressure sensing assembly to obtain the invention as specified in claim 1 as a matter of design choice. PNG media_image1.png 1127 1677 media_image1.png Greyscale As to claim 2. D1 discloses wherein the pressure sensing assembly (sensing mat 20 in fig. 4) includes a piezo-resistive layer ([0020] sensing mat 20 includes a top cover 30, a first layer 32, a second layer 34, a third layer 36, and a bottom cover 38; [0029] Second layer 34 is an elastically stretchable fabric that includes materials having one or more electrical characteristics that change in response to applied pressure. In one embodiment, layer 34 is a piezoresistive layer). As to claim 3 D1 discloses wherein the pressure sensing assembly (sensing mat 20 in fig. 4) further includes a top conductive layer ([0022] As shown in FIGS. 2 and 3, first layer 32 includes a plurality of conductive rows 40) and a bottom conductive layer ([0031] Third layer 36 is formed in the same manner as first layer 32, third layer 36 will include alternating layers of parallel conductive columns 44). As to claim 4. D1 discloses wherein the piezo-resistive layer ([0029] layer 34 is a piezoresistive layer) is located between the top conductive layer ([0022] As shown in FIGS. 2 and 3, first layer 32 includes a plurality of conductive rows 40) and the bottom conductive layer ([0031] Third layer 36 is formed in the same manner as first layer 32, third layer 36 will include alternating layers of parallel conductive columns 44) As to claim 5 D1 discloses wherein the top conductive layer ([0022] As shown in FIGS. 2 and 3, first layer 32 includes a plurality of conductive rows 40) includes a plurality of rows of conductive pathways (fig. 2 shows conductive rows 40) and the bottom conductive layer ([0031] Third layer 36 is formed in the same manner as first layer 32, third layer 36 will include alternating layers of parallel conductive columns 44) includes a plurality of columns of conductive pathways (fig. 2 shows conductive columns 44). As to claim 6 D1 discloses wherein the plurality of rows of conductive pathways extend transversely to the plurality of columns of conductive pathways and overlap to form the plurality of sensing regions (fig. 2). As to claim 7 D1 discloses wherein the plurality of rows includes five or more rows of conductive pathways (fig. 2 shows 11 conductive rows 40) and the plurality of columns includes five or more columns of conductive pathways (fig. 2 shows 7 conductive columns) defining at least 25 sensing regions (a 7 x 11 matrix has > 25 intersections/sensing regions). As to claim 13. D1 as modified does not explicitly disclose wherein a number of the plurality of inflatable cells is equal to a number of the plurality of sensing regions. However, D1 does disclose that the number of sensing locations where pressure is measured is changeable ([0032]). At the time of the invention, it would have been obvious to a person of ordinary skill in the art to select the number of sensing locations to correspond to the number of cells. Applicant has not disclosed that wherein the number of inflatable cells is equal to the number of sensing regions provides an advantage, is used for a particular purpose or solves a stated problem. One of ordinary skill in the art, furthermore, would have expected Applicant’s invention to perform equally well with the claimed ratio of cells to sensing regions or any other ratio as disclosed in D1 ([0032]) because both provide a measure of pressure at a desired point, the greater ratio disclosed by D1 merely provides improved sensing resolution. Therefore, it would have been obvious to combine to one of ordinary skill in this art to choose a ratio of cells to sensing regions of 1:1 to obtain the invention as specified in claim 13 as a matter of design choice. However, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions (i.e. a ratio of cells to sensing regions) would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device (MPEP 2144.04). As to claim 14. D1 as modified does not explicitly disclose wherein each of the sensing regions includes a single one of the inflatable cells aligned therewith. Applicant has not disclosed that wherein each of the sensing regions includes a single one of the inflatable cells aligned therewith provides an advantage, is used for a particular purpose or solves a stated problem. One of ordinary skill in the art, furthermore, would have expected Applicant’s invention to perform equally well with the claimed ratio of cells to sensing regions or any other ratio as disclosed in D1 ([0032]) because both provide a measure of pressure at a desired point, the greater ratio disclosed by D1 merely provides improved sensing resolution and a single sensing region per cell is a known minimum. Therefore, it would have been obvious to combine to one of ordinary skill in this art to choose wherein each of the sensing regions includes a single one of the inflatable cells aligned therewith to obtain the invention as specified in claim 14 as a matter of design choice. However, where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed relative dimensions (i.e. a ratio of cells to sensing regions) would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device (MPEP 2144.04). Claim(s) 8 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented), and further in view of US 6,721,980, hereinafter D3 (previously presented). As to claim 8. D1 as modified by D4 does not disclose further including a first protective layer and a second protective layer, and wherein the piezo-resistive layer, the top conductive layer, and the bottom conductive layer are sandwiched between the first protective layer and the second protective layer. However, D3 is in a related field and teaches a patient support assembly (11, figs. 1-4) which includes a sensor layer (see annotated figures 4-5; 14 in fig. 4) which includes a first protective layer (108 in fig. 5) and a second protective layer (108 in fig. 5), and wherein a piezo-resistive layer (14; see annotated figure), a top conductive layer (see annotated figure), and a bottom conductive layer (see annotated figure) are sandwiched between the first protective layer (108) and the second protective layer (108). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D3 (directed to a patient support) and arrived at the amended claim. One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. choosing from a known sensor) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. the claimed sensor provides a known benefit per col. 5, lns. 19-49). It would be obvious to one of ordinary skill in the art to use the teachings of D3 to modify D1 in view D4 for the purpose of providing an improved surface for preventing and treating pressure ulcers (col. 1, lns. 9-11). PNG media_image2.png 1151 1545 media_image2.png Greyscale Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented), and further in view of US 2004/0159219 A1, hereinafter D5 (necessitated by amendment). As to claim 9. D1 as modified by D4 does not disclose wherein the at least one pressure redistribution assembly is radiolucent. However, D5 is in a related field (fig. 1 shows a bed with inflatable lifting cells 102-146, [0037]-[0038]) and teaches it is known to use radiolucent materials ([0073]-[[0077]). It would be obvious to one of ordinary skill in the art to use the teachings of D5 to modify D1 in view of D4 for the purpose of to facilitate fluoroscopy and the taking of conventional X-rays ([0073]). An invention is obvious where some teaching, suggestion, or motivation in the prior art would have led one of ordinary skill to modify the prior art reference or to combine prior art reference teachings to arrive at the claimed invention. Claim(s) 10 and 21 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented) and further in view of US 20230181396 A1, hereinafter D6. As to claim 10. D1 as modified does not disclose the memory further includes instructions that cause the processor to, after a magnitude of pressure threshold is obtained, wait a period of time that the measurement of pressure is above the magnitude of pressure threshold before redistributing the medium. D6 is in a related field of a system for supporting a body of a user and teaches a controller with instructions in memory ([0014] controller comprising a processor, wherein the processor is configured and programmed to: after a magnitude of pressure threshold is obtained, wait a period of time that the measurement of pressure is above the magnitude of pressure threshold before redistributing the medium ([0018] in some embodiments, the system also comprises a controller operatively associated with each of the cells within the plurality of the cells, the controller comprising a processor, wherein the processor is configured and programmed to measure a duration of time the compressible fluid is contained in the bladder of each cell to determine a pressure time-value for each cell, compare the pressure-time value of each cell to a predetermined threshold, and lower the pressure of a cells within the plurality of cells for which the pressure-time value exceeds the predetermined threshold, and maintain or increase the pressure of cells within the plurality of cells for which the pressure-time value does not exceed the predetermined threshold). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D6 (directed to a patient support surface and control thereof) and arrived at the claimed subject matter. One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. utilizing a controller with an interface) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. an interface for a controller enables interaction with the controller and its associated functions; the controller monitors the pressure and determines the pressure-time value to minimize risk of injury to an occupant, [0018]-[0022]). As to claim 21. D1 as modified teaches the patient table of claim 1, but does not disclose further including a user interface including a display, wherein the memory further includes instructions that cause the processor to: generate on the display, the plurality of sensing regions; and if the measurement of pressure is above the threshold, generate a signal to highlight pressure sensing regions associated with a location of where the pressure is above the threshold. D6 is in a related field of a system for supporting a body of a user and teaches including a user interface including a display (shown but not numbered in fig. 8B), wherein a memory further includes instructions that cause a processor to ([0014] controller comprising a processor, wherein the processor is configured and programmed to: independently control the pressure of the compressible fluid to at least 10 mmHg, and the height of each bladder to an accuracy of +/−20 mm; and record and/or display the pressure and/or the height of each bladder): generate on the display (shown but not numbered in fig. 8B), the plurality of sensing regions ([0046] FIG. 8A shows an image of a display of a graphical user interface of a system displaying color-coded height depictions of a plurality of cells; FIG. 15 schematically depicts a GUI 1500 of a controller configured and programmed to display three different views of color-coded pressure and height maps of the overall support surface representing the body support topology); and if the measurement of pressure is above the threshold, generate a signal to highlight pressure sensing regions associated with a location of where the pressure is above the threshold ([0172] for each cell where a pressure-time threshold for injury is reached, the control system may do one or more of alerting an operator of the device or adjusting the pressure/bladder height of the cell (and/or surrounding or distant cells) to reduce the pressure applied to below the threshold and/or reposition the patient to redistribute applied forces to achieve a similar effect). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D6 (directed to a patient support surface and control) and arrived at the claimed subject matter. One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. utilizing a controller with an interface) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. an interface for a controller enables interaction with the controller and its associated functions). Claim(s) 11 and 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented) and further in view of US 2014/0101861, hereinafter D2. As to claim 11 D1 as modified by D4 teaches further including an output port (interface between 54 and 56 in fig. 4) and at least one cushion defining the patient support surface located in an outer envelope ([0021] top cover 30 and bottom cover 38 are sealed together about their periphery to thereby envelope first, second, and third layers 32, 34, and 36), but does not disclose wherein the at least one pressure redistribution assembly is located in the cushion outer envelope, and wherein a power conduit operably connects the pressure redistribution assembly to the output port. D2 is in a related field and teaches a patient support (100 in fig. 3) which has a pressure redistribution assembly (inflatable support 210 in fig. 5) which is located within an envelope 150 of patient support (fig. 4 and [0093]) and a power conduit assembly (178, 184, 188 are connected via interface 160). An invention is obvious where some teaching, suggestion, or motivation in the prior art would have led one of ordinary skill to modify the prior art reference or to combine prior art reference teachings to arrive at the claimed invention. It would be obvious to one of ordinary skill in the art to use the teachings D2 to arrange the components of D1 in view of D4 to provide the claimed recitation for the purpose of a unitary patient support assembly which is compact and convenient and provides improved patient support ([0005]). As to claim 20. D1 as modified does not disclose wherein the power conduit extends through and is hermetically sealed (interpreted per the specification at) to the envelope. D4 is in a related filed of patient support surface control and teaches it is known to provide a substantially fluid-proof seal for a power cord passing into a mattress ([0405] coupling the umbilical 3400 to the overmold 3382, the power cord 3222 is permitted to exit the mattress 3200, while maintaining a substantially fluid-proof seal that inhibits ingress of fluids into the mattress 3200; fig. 107). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D4 (directed to a patient support surface control) and arrived at pressure sensing mattress with a sealed interface for a control line). One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. forming sensor pad 20 with a sealed interface) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. a control line is permitted to exit the pad, while maintaining a substantially fluid-proof seal that inhibits ingress of fluids into the pad 20). Claim(s) 16-18 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 2019/0262201 A1, hereinafter D4 (previously presented) and further in view of US 2014/0101861, hereinafter D2, as applied to claim 11, and further in view of US 6,721,980, hereinafter D3. As to claim 16. D1 as modified does not explicitly disclose the following which is taught by D3: wherein the at least one cushion includes an upper cushion layer that is located proximate to the patient support surface and a lower cushion layer that is spaced from the patient support surface by the upper cushion layer. D3 is in a related field and teaches a patient support assembly (11, figs. 1-4) and teaches at least one cushion includes an upper cushion layer (collectively 34, 40 and 38) that is located proximate to a patient support surface (indicated by 11) and a lower cushion layer (foam/air support layer 36) that is spaced from the patient support surface (indicated by 11) by the upper cushion layer (collectively 34, 40 and 38). It would be obvious to one of ordinary skill in the art to use the teachings of D3 to modify D1 for the purpose of providing an improved surface for preventing and treating pressure ulcers (col. 1, lns. 9-11). As to claim 17. D1 as modified does not explicitly disclose the following which is taught by D3: wherein a pressure redistribution assembly (upper mattress layer 12 and sensor layer 14) is located between the upper cushion layer (collectively 34, 40 and 38) and the lower cushion layer (36). D3 is in a related field and teaches a patient support assembly (11, figs. 1-4) and teaches at least one cushion includes an upper cushion layer (collectively 34, 40 and 38) that is located proximate to a patient support surface (indicated by 11) and a lower cushion layer (foam/air support layer 36) that is spaced from the patient support surface (indicated by 11) by the upper cushion layer (collectively 34, 40 and 38). It would be obvious to one of ordinary skill in the art to use the teachings of D3 to modify D1 for the purpose of providing an improved surface for preventing and treating pressure ulcers (col. 1, lns. 9-11). As to claim 18. D1 as modified does not explicitly disclose the following which is taught by D3: wherein the pressure redistribution assembly (upper mattress layer 12 and sensor layer 14) is located along a top surface of the lower cushion layer (on support layer 9, fig. 4). D3 is in a related field and teaches a patient support assembly (11, figs. 1-4) and teaches at least one cushion includes an upper cushion layer (collectively 34, 40 and 38) that is located proximate to a patient support surface (indicated by 11) and a lower cushion layer (foam/air support layer 36) that is spaced from the patient support surface (indicated by 11) by the upper cushion layer (collectively 34, 40 and 38). It would be obvious to one of ordinary skill in the art to use the teachings of D3 to modify D1 for the purpose of providing an improved surface for preventing and treating pressure ulcers (col. 1, lns. 9-11). Claim(s) 22 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2013/0091961, hereinafter D1 (previously presented), in view of US 20230181396 A1, hereinafter D6 (cited in response to the amendment). As to claim 22. D1 discloses a patient table (fig. 1) comprising: a patient support surface (generally top surface of mattress 22) for supporting a patient (this is interpreted as a statement of intended use and it has been held that a recitation with respect to the manner in which a claimed apparatus is intended to be employed does not differentiate the claimed apparatus from a prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2d 1647 (1987)); at least one pressure redistribution assembly (fig. 1 and fig. 4), each of the at least one pressure redistribution assemblies comprising: a pressure sensing assembly (sensing mat 20 in fig. 4 including associated electrical conductors 50 and preprocessing circuit boards 52. Each preprocessing circuit board may, in turn, be connected to an electronic control module 54) located proximate to the patient support surface (fig. 1) to measure a pressure between the patient support surface and the patient at a plurality of sensing regions ([0034] Circuit boards 52 and control module 54 are designed to perform all of the electrical work necessary to determine the pressures being exerted at each of the pressure sensor locations of mat 20); a repositioning assembly (controller 26 and fluid bladders or cells 28), the repositioning assembly including a plurality of inflatable cells (fluid bladders or cells 28) overlapping the plurality of sensing regions ([0014] and fig 1 where sensing mat 20 above inflatable cell 28 = sensing region), a medium located within the inflatable cells ([0016] fluid inside cells), and an actuator for selectively redistributing a quantity of the medium between the inflatable cells ([0037] single controller, such as control module 54, may be used to control bladder or cell inflation and deflation); and a processor (mattress controller 26 and/or electronic control module includes memory [0017]) and a memory ([0017]) containing instructions that, when executed by the processor (mattress controller 26 includes memory [0017]), cause the processor (mattress controller 26 includes memory [0017]): receive a measurement of the pressure from the pressure sensing assembly ([0017] mattress controller 26 will include a set of electronic components that are designed to carry out the functions of controlling the inflation and deflation of the bladders or cells 28, and communicating with pressure mat 20; electronic control module 54 is in electrical communication with mattress controller 26); determine if the measurement of pressure is above a threshold ([0038] When control module 54 outputs information indicating that a specific sensor is detecting a pressure that is undesirably high, mattress controller 26 will be able to determine which air zone this corresponds to and adjust the pressure in that zone accordingly; [0040]). D1 does not disclose: a display; generate on the display, the plurality of sensing regions; or if the measurement of pressure is above the threshold, generate a signal to highlight pressure sensing regions associated with a location of where the pressure is above the threshold. D6 is in a related field of a system for supporting a body of a user and teaches including a user interface including a display (shown but not numbered in fig. 8B), wherein a memory including instructions that cause a processor to ([0014] controller comprising a processor, wherein the processor is configured and programmed to: independently control the pressure of the compressible fluid to at least 10 mmHg, and the height of each bladder to an accuracy of +/−20 mm; and record and/or display the pressure and/or the height of each bladder): generate on the display (shown but not numbered in fig. 8B), the plurality of sensing regions ([0046] FIG. 8A shows an image of a display of a graphical user interface of a system displaying color-coded height depictions of a plurality of cells; FIG. 15 schematically depicts a GUI 1500 of a controller configured and programmed to display three different views of color-coded pressure and height maps of the overall support surface representing the body support topology); and if the measurement of pressure is above the threshold, generate a signal to highlight pressure sensing regions associated with a location of where the pressure is above the threshold ([0172] for each cell where a pressure-time threshold for injury is reached, the control system may do one or more of alerting an operator of the device or adjusting the pressure/bladder height of the cell (and/or surrounding or distant cells) to reduce the pressure applied to below the threshold and/or reposition the patient to redistribute applied forces to achieve a similar effect). Accordingly, it would have been obvious to one of ordinary skill in the art before the claimed invention was effectively filed to have combined modified D1 (directed to a pressure sensing mattress) and D6 (directed to a patient support surface and control) and arrived at the claimed subject matter. One of ordinary skill in the art would have been motivated to make such a combination because all of the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods (e.g. utilizing a controller with an interface) with a reasonable expectation of success and with no change in their respective functions and one of ordinary skill in the art would have recognized that the results of the combination were predictable (e.g. an interface for a controller enables interaction with the controller and its associated functions). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. The prior art made of record on the attached PTOL-892 and not relied upon is considered pertinent to applicant's disclosure as each further discloses a state of the art. The examiner has pointed out particular references contained in the prior art of record in the body of this action for the convenience of the applicant. Although the specified citations are representative of the teachings in the art and are applied to the specific limitations within the individual claim, other passages and figures may apply as well. Applicant should consider the entire prior art as applicable as to the limitations of the claims. It is respectfully requested from the applicant, in preparing the response, to consider fully the entire reference as potentially teaching all or part of the claimed invention, as well as the context of the passage as taught by the prior art or pointed out by the examiner. Inquiry Any inquiry concerning this communication or earlier communications from the examiner should be directed to J. T. Newton, Esq. whose telephone number is (313)446-4899. The examiner can normally be reached 0700-1500 M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, SPE Justin Mikowski can be reached at (571) 272-8525. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /J. T. Newton/Primary Examiner, Art Unit 3673 11 August 2026 * * * * *
Read full office action

Prosecution Timeline

May 22, 2024
Application Filed
Dec 11, 2025
Non-Final Rejection (signed) — §103, §112
Jan 21, 2026
Non-Final Rejection mailed — §103, §112
May 21, 2026
Response Filed
Aug 13, 2026
Final Rejection mailed — §103, §112
Sep 21, 2026
Interview Requested
Sep 28, 2026
Examiner Interview Summary
Sep 28, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745849
SYSTEMS AND METHODS FOR MODULAR FURNITURE
2y 1m to grant Granted Sep 29, 2026
Patent 12746857
SEAT LOCKING RELEASE DEVICE
1y 10m to grant Granted Sep 29, 2026
Patent 12744513
ACOUSTIC WAVE DEVICE HAVING STACKED PIEZOELECTRIC LAYERS BETWEEN ELECTRODES
4y 6m to grant Granted Sep 22, 2026
Patent 12734084
ASSISTANCE DEVICE AND MOVING DEVICE USING SAME
2y 2m to grant Granted Sep 15, 2026
Patent 12733749
SPRING CONNECTING STRUCTURE, ROW OF SPRINGS, ELASTIC MATTESS, AND METHOD FOR USING ELASTIC MATTESS
2y 2m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+22.4%)
2y 3m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 872 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month